Monday, 29. May 2017

IDT Biologika inaugurates its new research and development building in Riems

After two years of construction, IDT Biologika is celebrating the opening of its new research and development building at its Riems site in Greifswald. “The new building in Riems is an embodiment of IDT’s dynamic strategy, expanding our manufacturing capacities at the Riems site with a continued focus on outstanding quality. These state-of-the-art laboratories will also allow us to intensify our research for future innovative proprietary products in the animal health field,” says IDT Biologika CEO Dr. Ralf Pfirmann. “Our employees in Mecklenburg-Western Pomerania will be working in cutting-edge jobs and making a significant contribution to IDT’s future.”

Just two years after German Chancellor Angela Merkel laid the cornerstone for the project, IDT Biologika in Riems is inaugurating its new research building with a public ceremony. “We kept to our €10.5 million budget and brought the work in on schedule,” reports Dr. Jörg Köhler, CEO of IDT Biologika (Riems). “Thirty new laboratories with up to 60 work stations have been created on some 1,750 square meters. Both labs and work stations have state-of-the-art equipment and fixtures. Around 50 companies took part in the planning and construction work, in many cases local enterprises from Mecklenburg-Western Pomerania, but also specialized companies from throughout Germany.” Along with 1,400 cubic meters of concrete – according to Dr. Köhler – 125 km of conduits were laid for wiring, electrical installations, computing and building automation. The seven refrigerators and two cold storage cells had to meet the highest quality requirements. While outdoors, 29 trees were planted on the IDT site and surrounding area of Riems.

“IDT Biologika is strongly engaged in research, development and innovation. Innovation is a key driver of sustainable growth and employment. Companies can only take hold in the market with internationally competitive products and services. We need more of these in Mecklenburg-Western Pomerania. That is why we want to strengthen this sector,” announced Harry Glawe, Mecklenburg-Western Pomerania Minister of the Economy, Employment and Health.

IDT Biologika celebrated the inauguration of the new building before the laboratories were cleanroom certified, so that the many guests, including Harry Glawe, Economy Minister for Mecklenburg-Western Pomerania, Prof. Franz J. Conraths, Vice President of the Friedrich Loeffer Institute, and Carsten Klocke, Managing Partner of Klocke Holding, could tour the new labs and facilities.

News Overview

IDT Biologika inaugurates new multifunctional production facility for vaccines at BioPharmaPark area more info

Ceva completes acquisition more info

IDT Biologika to concentrate on human vaccines and pharmaceuticals more info

Ceva Santé Animale and IDT Biologika GmbH more info

CMO Leadership Awards 2019 more info

IDT Biologika Awarded 10-Year NIH Contract more info

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info

25th anniversary of the privatization of IDT Biologika more info

IDT Biologika acquires Dr. Felgenträger, located in the BioPharmaPark Dessau more info

CMO Leadership Award 2018 more info